NO20090994L - 2-aminobenzoxazol karboxamider som 5HT3 modulatorer - Google Patents
2-aminobenzoxazol karboxamider som 5HT3 modulatorerInfo
- Publication number
- NO20090994L NO20090994L NO20090994A NO20090994A NO20090994L NO 20090994 L NO20090994 L NO 20090994L NO 20090994 A NO20090994 A NO 20090994A NO 20090994 A NO20090994 A NO 20090994A NO 20090994 L NO20090994 L NO 20090994L
- Authority
- NO
- Norway
- Prior art keywords
- aminobenzoxazole
- carboxamides
- modulators
- compositions
- iii
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
- C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/14—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing 9-azabicyclo [3.3.1] nonane ring systems, e.g. granatane, 2-aza-adamantane; Cyclic acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Otolaryngology (AREA)
- Child & Adolescent Psychology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US82164606P | 2006-08-07 | 2006-08-07 | |
PCT/US2007/075378 WO2008019372A2 (fr) | 2006-08-07 | 2007-08-07 | 2-aminobenzoxazole carboxamides en tant que modulateurs de 5ht3 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20090994L true NO20090994L (no) | 2009-05-04 |
Family
ID=38686790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20090994A NO20090994L (no) | 2006-08-07 | 2009-03-05 | 2-aminobenzoxazol karboxamider som 5HT3 modulatorer |
Country Status (14)
Country | Link |
---|---|
US (1) | US7863271B2 (fr) |
EP (1) | EP2061460A2 (fr) |
JP (1) | JP5512268B2 (fr) |
KR (1) | KR101417159B1 (fr) |
CN (1) | CN101528225B (fr) |
AU (1) | AU2007281678B2 (fr) |
BR (1) | BRPI0716069A2 (fr) |
CA (1) | CA2660349A1 (fr) |
IL (1) | IL196949A (fr) |
MX (1) | MX2009001494A (fr) |
NO (1) | NO20090994L (fr) |
NZ (1) | NZ574756A (fr) |
RU (1) | RU2448105C2 (fr) |
WO (1) | WO2008019372A2 (fr) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7863271B2 (en) | 2006-08-07 | 2011-01-04 | Albany Molecular Research, Inc. | 2-aminobenzoxazole carboxamides as 5HT3 modulators |
JP2011512340A (ja) * | 2008-02-15 | 2011-04-21 | エフ.ホフマン−ラ ロシュ アーゲー | 3−アルキルピペラジン誘導体及びその使用 |
DE102008022221A1 (de) | 2008-05-06 | 2009-11-12 | Universität des Saarlandes | Inhibitoren der humanen Aldosteronsynthase CYP11B2 |
AU2009260469B2 (en) * | 2008-05-29 | 2014-02-13 | Albany Molecular Research, Inc. | 5-HT3 receptor modulators, methods of making, and use thereof |
WO2010048514A1 (fr) * | 2008-10-23 | 2010-04-29 | Albany Molecular Research, Inc. | Synthèse de composés de 2-amino-benzoxazole |
AU2010273732A1 (en) | 2009-07-14 | 2012-02-09 | Albany Molecular Research, Inc. | 5-HT3 receptor modulators, methods of making, and use thereof |
US8541404B2 (en) | 2009-11-09 | 2013-09-24 | Elexopharm Gmbh | Inhibitors of the human aldosterone synthase CYP11B2 |
JP5840143B2 (ja) | 2010-01-11 | 2016-01-06 | アストライア セラピューティクス, エルエルシーAstraea Therapeutics, Llc | ニコチン性アセチルコリン受容体モジュレーター |
ES2553387T3 (es) | 2010-09-13 | 2015-12-09 | Otsuka Pharmaceutical Co., Ltd. | Compuestos heterocíclicos para el tratamiento o la prevención de trastornos causados por neurotransmisión reducida de serotonina, norepinefrina o dopamina |
JP6415982B2 (ja) * | 2012-03-12 | 2018-10-31 | 大塚製薬株式会社 | 複素環化合物 |
JPWO2014051055A1 (ja) * | 2012-09-28 | 2016-08-22 | 東レ株式会社 | キヌクリジンウレア誘導体及びその医薬用途 |
CN103113321B (zh) * | 2013-02-27 | 2015-02-18 | 南通大学 | 2-(甲硫基)苯并[d]噁唑-5-羧酸及其制备方法 |
ES2714705T3 (es) * | 2013-07-10 | 2019-05-29 | Meiji Seika Pharma Co Ltd | Inhibidor de PDE4 novedoso |
CN105745198B (zh) * | 2013-11-08 | 2018-09-21 | 橘生药品工业株式会社 | 羧甲基哌啶衍生物 |
DK3560925T3 (da) * | 2016-12-26 | 2021-06-28 | Meiji Seika Pharma Co Ltd | Hidtil ukendt forbindelse og farmaceutisk acceptabelt salt deraf |
MA52183A (fr) | 2018-04-06 | 2021-02-17 | H Lundbeck As | Procédé de préparation de 2,2-diméthylpipérazine |
WO2023287241A1 (fr) * | 2021-07-15 | 2023-01-19 | 주식회사 휴사이온 | Nouveau composé dérivé de benzoxazolamine et composition pharmaceutique le comprenant pour prévenir ou traiter le cancer |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5482653A (en) * | 1989-05-30 | 1996-01-09 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Fluoro-chloro-benzene derivatives |
US5260303A (en) | 1991-03-07 | 1993-11-09 | G. D. Searle & Co. | Imidazopyridines as serotonergic 5-HT3 antagonists |
JP3193560B2 (ja) | 1993-04-16 | 2001-07-30 | 明治製菓株式会社 | 新規ベンゾオキサゾール誘導体 |
PT975327E (pt) * | 1997-04-18 | 2003-11-28 | Janssen Pharmaceutica Nv | Uso de antagonistas de 5ht3 para estimular a lavagem intestinal |
GB0003256D0 (en) * | 2000-02-11 | 2000-04-05 | Darwin Discovery Ltd | Heterocyclic compounds and their therapeutic use |
MXPA04003986A (es) | 2001-10-26 | 2004-07-23 | Upjohn Co | Carboxamidas hetero-biciclicas n-azabiciclico sustituidas como agonistas nachr. |
BR0314485A (pt) * | 2002-09-25 | 2005-07-26 | Memory Pharm Corp | Indazóis, benzotiazóis e benzoisotiazóis, composto, composição farmacêutica, método desativação/estimulação seletiva de receptores nicotìnicos de a-7 em um mamìfero e método de tratamento e/ou prevenção de uma doença com os mesmos |
US7307094B2 (en) * | 2005-02-17 | 2007-12-11 | Amr Technology, Inc. | Benzoxazole carboxamides for treating CINV and IBS-D |
WO2008019363A2 (fr) | 2006-08-07 | 2008-02-14 | Albany Molecular Research, Inc. | 2-alkylbenzoxazole carboxamides en tant que modulateurs de 5ht3 |
US7863271B2 (en) | 2006-08-07 | 2011-01-04 | Albany Molecular Research, Inc. | 2-aminobenzoxazole carboxamides as 5HT3 modulators |
AU2009260469B2 (en) | 2008-05-29 | 2014-02-13 | Albany Molecular Research, Inc. | 5-HT3 receptor modulators, methods of making, and use thereof |
-
2007
- 2007-08-07 US US11/835,178 patent/US7863271B2/en not_active Expired - Fee Related
- 2007-08-07 CA CA002660349A patent/CA2660349A1/fr not_active Abandoned
- 2007-08-07 BR BRPI0716069-0A2A patent/BRPI0716069A2/pt not_active IP Right Cessation
- 2007-08-07 RU RU2009108327/04A patent/RU2448105C2/ru not_active IP Right Cessation
- 2007-08-07 NZ NZ574756A patent/NZ574756A/en not_active IP Right Cessation
- 2007-08-07 EP EP07813855A patent/EP2061460A2/fr not_active Withdrawn
- 2007-08-07 KR KR1020097004727A patent/KR101417159B1/ko not_active IP Right Cessation
- 2007-08-07 MX MX2009001494A patent/MX2009001494A/es active IP Right Grant
- 2007-08-07 AU AU2007281678A patent/AU2007281678B2/en not_active Ceased
- 2007-08-07 WO PCT/US2007/075378 patent/WO2008019372A2/fr active Application Filing
- 2007-08-07 CN CN2007800366711A patent/CN101528225B/zh not_active Expired - Fee Related
- 2007-08-07 JP JP2009523961A patent/JP5512268B2/ja not_active Expired - Fee Related
-
2009
- 2009-02-08 IL IL196949A patent/IL196949A/en not_active IP Right Cessation
- 2009-03-05 NO NO20090994A patent/NO20090994L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL196949A0 (en) | 2009-11-18 |
JP5512268B2 (ja) | 2014-06-04 |
US20080255114A1 (en) | 2008-10-16 |
US7863271B2 (en) | 2011-01-04 |
NZ574756A (en) | 2011-03-31 |
AU2007281678B2 (en) | 2012-08-02 |
RU2448105C2 (ru) | 2012-04-20 |
KR20090038034A (ko) | 2009-04-17 |
CA2660349A1 (fr) | 2008-02-14 |
AU2007281678A1 (en) | 2008-02-14 |
MX2009001494A (es) | 2009-04-23 |
CN101528225A (zh) | 2009-09-09 |
RU2009108327A (ru) | 2010-09-20 |
IL196949A (en) | 2013-11-28 |
JP2010500368A (ja) | 2010-01-07 |
WO2008019372A3 (fr) | 2008-04-17 |
EP2061460A2 (fr) | 2009-05-27 |
WO2008019372A2 (fr) | 2008-02-14 |
CN101528225B (zh) | 2013-07-17 |
BRPI0716069A2 (pt) | 2013-09-17 |
KR101417159B1 (ko) | 2014-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20090994L (no) | 2-aminobenzoxazol karboxamider som 5HT3 modulatorer | |
CY1109911T1 (el) | Πυρρολοβενζοδιαζεπινες | |
EA201100037A1 (ru) | Органические соединения | |
NO20091553L (no) | Fenylderivater og deres anvendelse som immunmodulatorer | |
MA33803B1 (fr) | Inhibiteur de bromodomaine de benzodiazépine | |
CY1113102T1 (el) | Ενωσεις φαινυλπροπιοναμιδιου και η χρηση αυτων | |
EA201001359A1 (ru) | Гетероциклические соединения в качестве ингибиторов cxcr2 | |
NO20084758L (no) | Sammensetninger anvendelige som inhibitorer av spenningsstyrte natriumkanaler | |
NO20090313L (no) | Derivater og analoger av N-etylkinoloner og N-etylazakinoloner | |
CR20120295A (es) | Triazolopiridinas | |
EA200970156A1 (ru) | Пиридизиноновые производные | |
NO20091395L (no) | Nye tiofenderivater | |
EA200801608A1 (ru) | Производные бензимидазолонкарбоновой кислоты | |
DK2134691T3 (da) | Quinolinonderivativer som parp- og tank-inhibitorer | |
EA200900945A1 (ru) | Новый способ синтеза агомелатина | |
UY29612A1 (es) | Compuestos quimicos ii | |
UY30748A1 (es) | Compuesto0s novedosos | |
UA94749C2 (en) | Benzimidazole modulators of vr1 | |
WO2010048358A3 (fr) | Inhibiteurs à base d'éthoxyphénylméthyle de sglt2 | |
CR10213A (es) | Moduladores de la proteína quinasa aurora | |
CY1112829T1 (el) | Νεα μεθοδος συνθεσης για την αγομελατινη | |
EA200801145A1 (ru) | Спироциклические производные хиназолина в качестве ингибиторов pde7 | |
MX2012006805A (es) | Indolil-piperidinil bencilaminas como inhibidores de beta-triptasa. | |
EA200900090A1 (ru) | Бензиламины, способ их получения и их применение в качестве противовоспалительных средств | |
EA201270255A1 (ru) | 5-фтор-2-оксопиримидин-1(2h)-карбоксилатные производные |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |